Vertex Pharmaceuticals Inc. buy UBS Group AG
Start price
17.10.24
/
50%
€459.95
Target price
17.10.25
€519.06
Performance (%)
-21.84%
End price
18.10.25
€359.50
Summary
This prediction ended on 18.10.25 with a price of €359.50. The prediction for Vertex Pharmaceuticals Inc. disappointed with a performance of -21.84%. UBS_Group_AG has a follow-up prediction for Vertex Pharmaceuticals Inc. where he still thinks Vertex Pharmaceuticals Inc. is a Buy. UBS_Group_AG has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y |
|---|---|---|---|
| Vertex Pharmaceuticals Inc. | 2.814% | 2.814% | -15.367% |
| iShares Core DAX® | -2.597% | -2.126% | 21.440% |
| iShares Nasdaq 100 | -3.356% | 0.640% | 10.982% |
| iShares Nikkei 225® | -4.112% | 0.711% | 18.225% |
| iShares S&P 500 | -2.520% | 0.874% | 4.314% |
Comments by UBS_Group_AG for this prediction
In the thread Trading Vertex Pharmaceuticals Inc.
Die von UBS_Group_AG gewählte maximale Laufzeit wurde überschritten
In the thread Vertex Pharmaceuticals Inc. diskutieren
Vertex Pharmaceuticals Incorporated (NASDAQ: VRTX) had its price target raised by analysts at UBS Group AG from $477.00 to $562.00. They now have a "buy" rating on the stock.
Ratings data for VRTX provided by MarketBeat
Current prediction by UBS_Group_AG for Vertex Pharmaceuticals Inc.
Vertex Pharmaceuticals Inc.
Start price
Target price
Perf. (%)
€344.35
05.08.25
05.08.25
€478.40
05.08.26
05.08.26
9.09%
09:23
09:23
Stopped prediction by UBS_Group_AG for Vertex Pharmaceuticals Inc.
Vertex Pharmaceuticals Inc.
Start price
Target price
Perf. (%)
€352.60
07.11.25
07.11.25
€473.22
07.11.26
07.11.26
6.54%
09:23
09:23
Vertex Pharmaceuticals Inc.
Start price
Target price
Perf. (%)
€459.85
05.11.24
05.11.24
€536.01
05.11.25
05.11.25
-21.69%
06.11.25
06.11.25